Ophthalmnological Examination.-Both orbital margins were tender, and the eyes and lids immobile. Both eyes were proptosed and both eyelids grossly swollen, the skin being erythematous. Both lacrimal passages were patent. There was gross conjunctival and circumcorneal congestion. The corneae were hazy and insensitive and the pupils dilated and fixed. The iris, lens, and vitreous were normal. Fundus examination showed slight dilatation and tortuosity of the retinal veins. Only projection of light was present in both eyes; hand movements could not be distinguished.
respiratory, and gastro-intestinal systems appeared to be normal. Neck rigidity was present and Kernig's sign was positive. There was tenderness over both mastoid regions.
Total white blood cell count 11 .200/c.mm. ( 
REVERIN IN CAVERNOUS SINUS THROMBOSIS
Progress.-Improvement began on the third day after admission, and one Decadron tablet was then given three times a day, and the dosage gradually tapered off. The proptosis and tenderness decreased and the pupils started reacting to light, though sluggishly. On July 1, 1965, the patient was finally discharged with only a very slight residual limitation of abduction in both eyes. Discussion Reverin (Hoechst Pharmaceuticals) is a pyrrolidinomethyl derivative of tetracycline (molecular formula C27H3308N3). It is water-soluble and free from any side-effects after intravenous administration. High blood and urinary levels are attained (Weizel and Dana, 1961) . Finland, Purcell, Wright, Del Love, Mou, and Kass (1954), Fussganger (1958) , arrd Dimmling, Hiiner, Lutzeyer, and Simon (1958) have shown that the potency and bacteriostatic range of Reverin corresponds to that of tetracycline hydrochloride. It has been widely used by various workers, including Koch and Bohn (1960) . Dimmling (1960) showed that a cumulative increase in the cerebrospinal fluid was not likely, and found a higher concentration in the aqueous humour 30 minutes after injection (in rabbits) than in the serum. Avedikian (1961) used Reverin subconjunctivally in thirty cases of serpiginous corneal ulcer. Kiichle and Dimmling (1961) advocated its use subconjunctivally as well as intravenously in severe intra-ocular infections. Nagpaul, Charan, and Sarda (1965) used it in the treatment of corneal ulcers.
The use of this drug has not hitherto been reported in cavernous sinus thrombosis. Our patient was so gravely ill as to raise doubts for his survival, with proptosis and severe pain, fever, and loss of vision, but no septic foci. He improved dramatically with 275 mg. Reverin injected intravenously daily for 13 days, and was discharged after 16 days. Summary A case is reported of cavernous sinus thrombosis with no history of any preceding septic focus, which was quickly relieved by the use of Reverin. 
